BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36698217)

  • 1. Deep learning based identification of bone scintigraphies containing metastatic bone disease foci.
    Ibrahim A; Vaidyanathan A; Primakov S; Belmans F; Bottari F; Refaee T; Lovinfosse P; Jadoul A; Derwael C; Hertel F; Woodruff HC; Zacho HD; Walsh S; Vos W; Occhipinti M; Hanin FX; Lambin P; Mottaghy FM; Hustinx R
    Cancer Imaging; 2023 Jan; 23(1):12. PubMed ID: 36698217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated classification of benign and malignant lesions in
    Perk T; Bradshaw T; Chen S; Im HJ; Cho S; Perlman S; Liu G; Jeraj R
    Phys Med Biol; 2018 Nov; 63(22):225019. PubMed ID: 30457118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.
    Aoki Y; Nakayama M; Nomura K; Tomita Y; Nakajima K; Yamashina M; Okizaki A
    Ann Nucl Med; 2020 Dec; 34(12):926-931. PubMed ID: 32955663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning-based algorithm improved radiologists' performance in bone metastases detection on CT.
    Noguchi S; Nishio M; Sakamoto R; Yakami M; Fujimoto K; Emoto Y; Kubo T; Iizuka Y; Nakagomi K; Miyasa K; Satoh K; Nakamoto Y
    Eur Radiol; 2022 Nov; 32(11):7976-7987. PubMed ID: 35394186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep neural network based artificial intelligence assisted diagnosis of bone scintigraphy for cancer bone metastasis.
    Zhao Z; Pi Y; Jiang L; Xiang Y; Wei J; Yang P; Zhang W; Zhong X; Zhou K; Li Y; Li L; Yi Z; Cai H
    Sci Rep; 2020 Oct; 10(1):17046. PubMed ID: 33046779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BS-80K: The first large open-access dataset of bone scan images.
    Huang Z; Pu X; Tang G; Ping M; Jiang G; Wang M; Wei X; Ren Y
    Comput Biol Med; 2022 Dec; 151(Pt A):106221. PubMed ID: 36334360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients].
    Jauković L; Ajdinović B; Janković Z; Dugonjić S
    Vojnosanit Pregl; 2006 Dec; 63(12):1001-5. PubMed ID: 17252703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of
    Kitajima K; Fukushima K; Yamamoto S; Kato T; Odawara S; Takaki H; Fujiwara M; Yamakado K; Nakanishi Y; Kanematsu A; Nojima M; Hirota S
    Nagoya J Med Sci; 2017 Aug; 79(3):387-399. PubMed ID: 28878443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparative study of
    Fonager RF; Zacho HD; Langkilde NC; Fledelius J; Ejlersen JA; Hendel HW; Haarmark C; Moe M; Mortensen JC; Jochumsen MR; Petersen LJ
    Acta Oncol; 2018 Aug; 57(8):1063-1069. PubMed ID: 29447047
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM
    Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Iterative Algorithm for Semisupervised Classification of Hotspots on Bone Scintigraphies of Patients with Prostate Cancer.
    Providência L; Domingues I; Santos J
    J Imaging; 2021 Aug; 7(8):. PubMed ID: 34460784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
    Arvola S; Seppänen M; Malaspina S; Mätzke S; Raiko J; Timonen KL; Ettala O; Jambor I; Anttinen M; Kuisma A; Löyttyniemi E; Boström PJ; Sohlberg A; Noponen T
    Nucl Med Commun; 2022 May; 43(5):510-517. PubMed ID: 35081092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
    Al-Muqbel KM; Yaghan RJ
    Medicine (Baltimore); 2016 May; 95(21):e3753. PubMed ID: 27227942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a deep learning algorithm for myopic maculopathy classification based on OCT images using transfer learning.
    He X; Ren P; Lu L; Tang X; Wang J; Yang Z; Han W
    Front Public Health; 2022; 10():1005700. PubMed ID: 36211704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A deep learning algorithm for detecting lytic bone lesions of multiple myeloma on CT.
    Faghani S; Baffour FI; Ringler MD; Hamilton-Cave M; Rouzrokh P; Moassefi M; Khosravi B; Erickson BJ
    Skeletal Radiol; 2023 Jan; 52(1):91-98. PubMed ID: 35980454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of (18)F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis.
    Niikura N; Hashimoto J; Kazama T; Koizumi J; Ogiya R; Terao M; Oshitanai R; Morioka T; Tsuda B; Okamura T; Saito Y; Iwaisako K; Iwamoto T; Hayashi N; Imai Y; Tokuda Y
    Breast Cancer; 2016 Jul; 23(4):662-7. PubMed ID: 26037335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoid tumor and bone metastases: diagnosis by somatostatin receptor scintigraphy].
    Banzo J; Abós MD; Prats E; Razola P; García S; Alonso V; Velilla J; García F; Ubieto MA; Tardín L
    Rev Esp Med Nucl; 2004; 23(6):394-402. PubMed ID: 15625056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.